+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aripiprazole"

From
From
Schizophrenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Schizophrenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
Loading Indicator

Aripiprazole is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a dopamine partial agonist, meaning it works by stimulating dopamine receptors in the brain. Aripiprazole is also used to treat irritability and symptoms associated with autism spectrum disorder. It is available in both oral and injectable forms. Aripiprazole is generally well-tolerated and has fewer side effects than other antipsychotic medications. It is also less likely to cause weight gain and metabolic changes than other antipsychotics. The aripiprazole market is highly competitive, with many companies offering generic versions of the drug. Companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals are some of the major players in the market. Other companies such as Dr. Reddy's Laboratories, Lupin, and Torrent Pharmaceuticals also offer generic versions of the drug. Show Less Read more